The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksFrontier Ip Regulatory News (FIPP)

Share Price Information for Frontier Ip (FIPP)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 41.50
Bid: 40.00
Ask: 43.00
Change: 0.50 (1.22%)
Spread: 3.00 (7.50%)
Open: 41.50
High: 41.50
Low: 41.50
Prev. Close: 41.00
FIPP Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Alusid in collaboration with Imerys

30 Jan 2023 07:00

RNS Number : 1646O
Frontier IP Group plc
30 January 2023
 

Reach - a non-regulatory announcement

AIM: FIPP

30 January 2023

 

Frontier IP Group Plc

("Frontier IP" or the "Group")

 

 

Portfolio news - Alusid extends product range in collaboration with global speciality minerals group Imerys

 

Frontier IP, a specialist in commercialising intellectual property, notes the following announcement from portfolio company Alusid (the "Company") that it has successfully collaborated with Imerys, a world leader in specialty minerals to make floor tiles.

 

The collaboration started after Alusid was named as one of two winners in the Imerys Start-Up Innovation Factory competition launched last year, from sixty-five companies from around the world selected to participate. The aim of the competition's first edition was to enable Imerys to research potential partners to collaborate on innovation to meet circular economy challenges.

 

Over the past few months, Alusid and Imerys have run two parallel trials to make products using Imerys by-products: the floor tiles, and another to make larger items such as coffee tables and worktops. Both were successful, and the floor tiles are now attracting commercial interest, including from a leading retailer. Frontier IP holds a 38.9 per cent equity stake in the Company.

 

Imerys generated €4.4 billion in revenues during 2021 and employs 16,300 people.

 

 

Frontier IP Chief Executive Neil Crabb said: "We're delighted with Alusid's success in, first, being one of only two winners from a global competition organised by a multinational group, and second, in developing a wholly new product from Imerys' by-products. Success provides further validation of the Company's unique technology to recycle industrial waste into premium-quality tiles and surfaces."

 

Alusid statement follows:

Alusid extends product range in collaboration with global speciality minerals group Imerys

 

Alusid has successfully produced high-quality, hard-wearing floor tiles made from 100 per cent recycled waste after being named as one of the winners in the Start-Up Innovation Factory competition launched by Imerys, a world leader in minerals-based specialty solutions.

 

The aim of the first edition of the competition, launched last year, was to enable Imerys to research potential partners to collaborate on innovation to meet circular economy challenges on technical themes, such as recovering and recycling construction material waste. Sixty-five start-ups from around the world were selected to participate.

 

Alusid has been trialling tile manufacture using six Imerys by-products over the past few months as a continuation of the competition. An Imerys team, led by Cédric Poilly, Customer Application Engineer for Ceramics EMEA, provided support . Two parallel projects were run: one making the floor tiles and the other larger items, such as coffee tables and worktops. Both proved successful, and the next step is to scale up the technology for industrial production.

 

Made from 100 per cent recycled waste, 90 per cent of which came from Imerys, the tiles use three by-products in the recipe, with scope to include additional materials directly produced by Imerys or from its customers.

 

The tiles have the same performance as those made from non-recycled materials, and have already attracted interest from potential customers, including a leading retail brand.

 

Benefits include the use and recycling of surplus raw materials and by-products that would normally go to waste. Alusid's processes consume less gas to manufacture than conventional tiles with energy usage potentially cut by more than 35 per cent because of lower firing temperatures and the use of dry powder granulation rather than spray drying. Water use is also reduced by up to 75 per cent.

 

Alasdair Bremner, Alusid's CEO said: "Working with Imerys on this project has expanded our available sources of recycled material and allowed us to create a product missing from our range, a hard-wearing, high-quality floor tile. Imerys extensive knowledge and their scale means they have the capacity to help us precise our business model and ultimately reduce the environmental impact of tile production. In the initial pilot trial, we had to deal with some warping and adapting with firing these unconventional materials. However, the results are promising enough for us to envision industrial trials. Our aim is to achieve porcelain stoneware classification on water absorption and breaking strength, making our tiles as good as tiles made from non-recycled materials."

 

Frederic Jouffret, Imerys Vice-President, Performance Minerals Science & Technology, said: "Working with start-ups through this challenge was very educational and promising for Imerys. The challenge itself has created a more structured approach for open innovation in the future."

 

 

Alusid statement ends

 

ENQUIRIES

 

 

Frontier IP Group Plc

T: 020 7332 2338

Neil Crabb, Chief Executive

Andrew Johnson, Communications & Investor Relations

Company website: www.frontierip.co.uk

neil@frontierip.co.uk

M: 07464 546 025

Allenby Capital Limited (Nominated Adviser)

Nick Athanas / George Payne

 

T: 0203 328 5656

 

 

 

 

ABOUT IMERYS:

The world leader in mineral-based specialty solutions for industry, with €4.4 billion revenue and 16,300 employees in 2021, Imerys delivers high value-added, functional solutions to diversified set of industrial sectors, from processing industries to consumer goods. The Group draws on its knowledge of applications, technological expertise and its material science know-how to deliver solutions based on beneficiation of its mineral resources, synthetic minerals and formulations. These contribute essential properties to customers' products and performance, including refractoriness, hardness, conductivity, opacity, durability, purity, lightness, filtration, absorption and repellency. Imerys is determined to develop responsibly, in particular by fostering the emergence of environmentally friendly products and processes.

 

ABOUT ALUSID

Alusid creates beautiful, premium-quality tiles and architectural surfaces The company creates beautiful, premium quality tiles and architectural surfaces by recycling industrial waste ceramics, glass and other materials much of which would otherwise end in landfill. Tiles are made from a minimum of 95 per cent recycled content and usually contain more.

 

The company's Sequel ranges are distributed exclusively by Parkside Architectural Tiles, the commercial arm of Topps Tiles. Sequel Vibe was named Wall Tile of The Year in The Tile Association's prestigious in 2020.

 

Alusid also makes its own products under the brand name SilicaStone distributed in the UK by Panaz. Customers include COS, part of H&M, Christian Dior, Nando's, Harrods, Selfridges, Amazon UK and Pret-a-Manger.

 

ABOUT FRONTIER IP

Frontier IP unites science and commerce by identifying strong intellectual property and accelerating its development through a range of commercialisation services. A critical part of the Group's work is involving relevant industry partners at an early stage of development to ensure technology meets real world demands and needs.

The Group looks to build and grow a portfolio of equity stakes and licence income by taking an active involvement in spin-out companies, including support for fund raising and collaboration with relevant industry partners at an early stage of development.

 

About Reach announcements

This is a Reach announcement. Reach is an investor communication service aimed at assisting listed and unlisted (including AIM quoted) companies to distribute media only / non-regulatory news releases into the public domain. Information required to be notified under the AIM Rules for Companies, Market Abuse Regulation or other regulation would be disseminated as an RNS regulatory announcement and not on Reach.

 

 

 

 

 

 

 

This information is provided by Reach, the non-regulatory press release distribution service of RNS, part of the London Stock Exchange. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.Reach is a non-regulatory news service. By using this service an issuer is confirming that the information contained within this announcement is of a non-regulatory nature. Reach announcements are identified with an orange label and the word “Reach” in the source column of the News Explorer pages of London Stock Exchange’s website so that they are distinguished from the RNS UK regulatory service. Other vendors subscribing for Reach press releases may use a different method to distinguish Reach announcements from UK regulatory news.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
NRANKOBDOBKDCDB
Date   Source Headline
2nd Dec 20227:00 amRNSThe Vaccine Group completes vaccine project
30th Nov 20225:00 pmRNSTotal Voting Rights
25th Nov 20222:23 pmRNSDirector/PDMR Shareholding
23rd Nov 20225:17 pmRNSDirector share transfers
18th Nov 20223:53 pmRNSExercise of Options & PDMR Shareholdings
11th Nov 20223:07 pmRNSDirector/PDMR Dealing
11th Nov 20227:00 amRNSPosting of Annual Report and Notice of AGM
8th Nov 20227:00 amRNSPulsiv announces £1.5m fundraise
1st Nov 20221:46 pmEQSFrontier IP Group 'rigged for a storm' but confident of more progress
27th Oct 20227:00 amRNSFinal Results
19th Oct 20224:22 pmRNSHolding(s) in Company
19th Oct 20223:29 pmRNSHolding(s) in Company
14th Oct 20227:00 amRNSElute Intelligence appoints Steve Cable as CEO
27th Sep 20227:00 amRNSPulsiv unveils power electronics technology
18th Aug 20223:20 pmRNSSale of shares in Exscientia
5th Aug 20227:00 amRNSCamGraPhIC announces £1.26 million fundraising
26th Jul 20224:26 pmRNSHolding(s) in Company
26th Jul 20224:07 pmRNSHolding(s) in Company
24th May 20227:00 amRNSCambridge Raman Imaging raises £1.1 million
19th May 20227:00 amRNSPublication of newsletter
12th Apr 20225:18 pmRNSHolding(s) in Company
17th Mar 20227:00 amRNSUnaudited Half Year Results
14th Feb 20227:00 amRNSSale of shares in Exscientia
11th Feb 20225:04 pmRNSHolding(s) in Company
11th Feb 20222:05 pmRNSHolding(s) in Company
10th Feb 20227:00 amRNSCambridge Raman Imaging wins European Union grant
25th Jan 20227:00 amRNSSale of shares in Exscientia
17th Jan 20225:56 pmRNSHolding(s) in Company
12th Jan 20227:00 amRNSTrading update
11th Jan 20227:00 amRNSCelerum launch first commercial product
9th Dec 20212:33 pmRNSResult of AGM
29th Nov 20217:00 amRNSTVG - milestone in development of COVID-19 vaccine
9th Nov 20217:00 amRNSPosting of Annual Accounts and Notice of AGM
28th Oct 20217:00 amRNSDirectorate Change
28th Oct 20217:00 amRNSFinal Results
15th Oct 20217:00 amRNSPublication of newsletter
1st Oct 20217:59 amRNSPricing of IPO of Exscientia in the United States
30th Sep 20217:00 amRNSCamGraPhIC raises £1.6 million
27th Sep 20213:56 pmRNSUpdate on proposed IPO of Exscientia
24th Sep 20217:00 amRNSHolding(s) in Company
13th Sep 20217:00 amRNSExscientia - Statement filed for proposed IPO
8th Sep 20211:24 pmRNSExscientia enters $70M collaboration
8th Jul 20217:00 amRNSCamGraPhIC loan facility of up to £1.5 million
15th Jun 20217:00 amRNSPulsiv appoints Adam Westcott as CFO
14th Jun 20217:00 amRNSNandi Proteins appoints David Flower as CEO
11th Jun 20217:00 amRNSPublication of newsletter
24th May 20217:00 amRNSPulsiv complete £1.5m fundraising and appoints CEO
19th May 202111:53 amRNSExscientia collaboration with Bristol Myers Squibb
6th May 20217:00 amRNSThe Vaccine Group appoints Jeremy Salt as CEO
30th Apr 20211:58 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.